Gen1E Lifesciences
Palo Alto, California, United States
GEn1E is a next generation biotechnology company turbocharging cures for rare and neglected diseases. GEn1E's unique solution is a hack to the biotech industry, getting medicines to the market 10X cheaper, 2X faster and 2X more likely to succeed than conventional therapies.Our lead program are Selective p38 alpha kinase inhibitors which provide a platform for the treatment of various aging and inflammatory diseases. Our first indication will be for a rare disease, Acute Lung injury (ALI)/Acute Respiratory Distress Syndrome (ARDS)- a disease with no FDA approved treatments, a mortality of 40% and a $20 Billion cost to society
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2018
- Website
- genielifesciences.com/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Gen1E Lifesciences?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now